Word

Status

Dead

Status Code

606

Status Date

Monday, June 19, 2017

Serial Number

85727303

Mark Type

2000

Filing Date

Wednesday, September 12, 2012

Published for Opposition

Tuesday, March 18, 2014

Abandoned Date

Monday, June 19, 2017

Trademark Owner History

Atreca, Inc. - Owner At Publication

Classifications

1 Diagnostic preparations and diagnostic kits comprised of buffers and reagents for clinical, medical laboratory, or research use; antibodies for clinical, medical laboratory, or research use; combinations of antibodies for clinical, medical laboratory, or research use; kits containing buffers and reagents for research use

5 Diagnostic preparations and diagnostic kits comprised of buffers and reagents for medical use; antibodies or antibody sequences for medical use, namely, medical diagnosis; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of infectious disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of cancer; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of autoimmune/inflammatory disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of cardiovascular disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of neurological disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of metabolic disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of respiratory disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of ophthalmic disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of infectious disease, cancer, or autoimmune disease in animals; biologics, namely, vaccines for prophylaxis or treatment of infectious disease or cancer in humans; biologics, namely, vaccines for prophylaxis or treatment of infectious disease or cancer in animals; combinations of antibodies or antibody sequences for medical use, namely, biological preparation for the treatment or prophylaxis of infectious disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of cancer; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of autoimmune/inflammatory disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of cardiovascular disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of neurological disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of metabolic disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of respiratory disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of ophthalmic disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of infectious disease, cancer, or autoimmune disease in animals; combinations of biologics, namely, vaccines for prophylaxis or treatment of infectious disease or cancer in humans; combinations of biologics, namely, vaccines for prophylaxis of treatment of infectious disease or cancer in animals

Color is not claimed as a feature of the mark.
The mark consists of a geometric design composed of three arrows pointing inward on a black background that forms its own multi-sided geometric design with three distinct sections, each corresponding to one of the arrows, and three black arrowheads pointing inwards.

Trademark Events

Jun 19, 2017

Abandonment Notice Mailed - No Use Statement Filed

Jun 19, 2017

Abandonment - No Use Statement Filed

Nov 22, 2016

Notice Of Approval Of Extension Request E-Mailed

Nov 20, 2016

Extension 5 Granted

Nov 10, 2016

Extension 5 Filed

Nov 10, 2016

Teas Extension Received

Apr 20, 2016

Notice Of Approval Of Extension Request E-Mailed

Apr 19, 2016

Extension 4 Granted

Apr 5, 2016

Extension 4 Filed

Apr 5, 2016

Teas Extension Received

Dec 3, 2015

Applicant/Correspondence Changes (Non-Responsive) Entered

Dec 3, 2015

Teas Change Of Owner Address Received

Dec 4, 2015

Notice Of Approval Of Extension Request E-Mailed

Dec 4, 2015

Corrected Noa E-Mailed

Dec 3, 2015

Divisional Processing Complete

Nov 13, 2015

Divisional Request Received

Dec 3, 2015

Extension 3 Granted

Nov 13, 2015

Extension 3 Filed

Nov 13, 2015

Teas Request To Divide Received

Nov 13, 2015

Teas Extension Received

May 15, 2015

Notice Of Approval Of Extension Request E-Mailed

May 14, 2015

Extension 2 Granted

Apr 29, 2015

Extension 2 Filed

Apr 29, 2015

Teas Extension Received

Jan 13, 2015

Applicant/Correspondence Changes (Non-Responsive) Entered

Jan 13, 2015

Case Assigned To Intent To Use Paralegal

Nov 6, 2014

Paper Received

Oct 29, 2014

Notice Of Approval Of Extension Request E-Mailed

Oct 27, 2014

Extension 1 Granted

Oct 27, 2014

Extension 1 Filed

Oct 27, 2014

Teas Extension Received

Oct 27, 2014

Teas Change Of Correspondence Received

Oct 22, 2014

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 22, 2014

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

May 13, 2014

Noa E-Mailed - Sou Required From Applicant

Mar 18, 2014

Official Gazette Publication Confirmation E-Mailed

Mar 18, 2014

Published For Opposition

Feb 26, 2014

Notification Of Notice Of Publication E-Mailed

Feb 10, 2014

Law Office Publication Review Completed

Feb 10, 2014

Assigned To Lie

Jan 22, 2014

Approved For Pub - Principal Register

Jan 22, 2014

Examiner's Amendment Entered

Jan 22, 2014

Notification Of Examiners Amendment E-Mailed

Jan 22, 2014

Examiners Amendment E-Mailed

Jan 22, 2014

Examiners Amendment -Written

Jul 25, 2013

Notification Of Final Refusal Emailed

Jul 25, 2013

Final Refusal E-Mailed

Jul 25, 2013

Final Refusal Written

Jul 16, 2013

Teas/Email Correspondence Entered

Jul 15, 2013

Correspondence Received In Law Office

Jul 15, 2013

Teas Response To Office Action Received

Jan 14, 2013

Notification Of Non-Final Action E-Mailed

Jan 14, 2013

Non-Final Action E-Mailed

Jan 14, 2013

Non-Final Action Written

Jan 7, 2013

Assigned To Examiner

Sep 19, 2012

Notice Of Design Search Code Mailed

Sep 18, 2012

New Application Office Supplied Data Entered In Tram

Sep 15, 2012

New Application Entered In Tram